<bill session="115" type="h" number="5799" updated="2023-01-11T13:39:31Z">
  <state datetime="2018-05-17">REPORTED</state>
  <status>
    <unknown datetime="2018-05-17"/>
  </status>
  <introduced datetime="2018-05-15"/>
  <titles>
    <title type="display">Medicaid Drug Review, Utilization, Good Governance Improvement Act</title>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to require as a condition of receipt of full Federal medical assistance percentage under Medicaid that State Medicaid plans have in place certain drug utilization review activities.</title>
    <title type="short" as="reported to house">Medicaid DRUG Improvement Act</title>
    <title type="short" as="reported to house">Medicaid Drug Review, Utilization, Good Governance Improvement Act</title>
    <title type="short" as="introduced">Medicaid DRUG Improvement Act</title>
    <title type="short" as="introduced">Medicaid Drug Review, Utilization, Good Governance Improvement Act</title>
  </titles>
  <sponsor bioguide_id="B001243"/>
  <cosponsors>
    <cosponsor bioguide_id="B001282" joined="2018-05-15"/>
    <cosponsor bioguide_id="K000387" joined="2018-05-15"/>
    <cosponsor bioguide_id="W000791" joined="2018-06-01"/>
  </cosponsors>
  <actions>
    <action datetime="2018-05-15">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-05-15" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2018-05-17">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2018-05-17" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </action>
    <action datetime="2018-06-12">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-728.</text>
    </action>
    <calendar datetime="2018-06-12" calendar="Union" number="563">
      <text>Placed on the Union Calendar, Calendar No. 563.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="hr" number="1099" relation="unknown"/>
    <bill session="115" type="h" number="6" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Adoption and foster care"/>
    <term name="Child health"/>
    <term name="Congressional oversight"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Health care costs and insurance"/>
    <term name="Health information and medical records"/>
    <term name="Medicaid"/>
    <term name="Mental health"/>
    <term name="Prescription drugs"/>
    <term name="State and local government operations"/>
  </subjects>
  <amendments/>
  <summary date="2018-11-16T15:17:57Z" status="Reported to House with amendment(s)">Medicaid Drug Review, Utilization, Good Governance Improvement Act or the Medicaid DRUG Improvement Act

This bill requires state Medicaid programs to establish drug-review and utilization requirements for enrollees, particularly with respect to opioid prescriptions. Drug use review programs must also identify prescribing or billing practices by providers that indicate abuse or excessive utilization.</summary>
  <committee-reports>
    <report>H. Rept. 115-728</report>
  </committee-reports>
</bill>
